-

Successfully Reversing Aging, Extended Longevity, Inc., Announces its Wefunder Campaign

MAUI, Hawaii--(BUSINESS WIRE)--Extended Longevity, a Hawaii-based longevity company focused on reversing the biomarkers of aging, announces a crowdfunding offering on Wefunder. You can learn about our offering here: https://wefunder.com/extended.longevity.inc

Extended Longevity has introduced a product line of ten (10) targeted phytotherapeutic formulations that have successfully demonstrated deceleration of the determinant factors of aging. The company is currently running medically supervised studies, with independent lab tests revealing that these formulations have regrown telomeres to lengths equivalent to a 10 year-old, significantly lowered inflammation, and rolled back the epigenetic clock by an astonishing 22% (15 years).

On the Extended Longevity website are case studies detailing before and after results of an initial test cohort, including a 68-year-old who successfully decelerated his epigenome biological age by 15 years, for two years in a row. “We now believe we have flattened the aging curve,” said CEO and Founder Steven M Schorr, “and we have initiated additional testing through an IRB (Investigative Review Board) study whose results will be available in the fall.” Additionally, the company has proven test results demonstrating a 14-year reduction in a 75-year-old, a 12-year reduction in a 58-year-old woman, and two 42-year-old men with age reversals of 10 and 12 years, among others. All have significantly regrown their telomeres to that of adolescents and maintain very low C-RP inflammation.

Extended Longevity has developed a patent-pending solution for aging with proven scientific results. This investment tranche will expand production capabilities, build brand awareness, and fund expanded ongoing trials to gather additional scientific data and show the continued success of its life-extending protocol.

CEO Steven Schorr is an entrepreneur and public company CEO and CSO with 48 years of experience. He is a patented inventor and scientist who has dedicated his career to creating data-driven products that work for the health and wellness industry.

Disclosures:

We are “testing the waters” to gauge investor interest in an offering under Regulation Crowdfunding. No money or other consideration is being solicited. If sent, it will not be accepted. No offer to buy securities will be accepted. No part of the purchase price will be received until a Form C is filed and only through Wefunder’s platform. Any indication of interest involves no obligation or commitment of any kind.

Contacts

Extended Longevity
Mark Matthews, 773.558.5781
sms@extendedlongevity.com

Extended Longevity


Release Versions

Contacts

Extended Longevity
Mark Matthews, 773.558.5781
sms@extendedlongevity.com

More News From Extended Longevity

Extended Longevity Enters XPRIZE Healthspan Competition with Groundbreaking Anti-Aging Solutions

KULA, Hawaii--(BUSINESS WIRE)--Extended Longevity, a pioneering company in the field of longevity and anti-aging, is proud to announce its entry into the prestigious $101 million dollar XPRIZE Healthspan competition. This move marks a significant milestone in Extended Longevity's commitment to revolutionize the way we understand and approach aging. Extended Longevity has made remarkable strides in reversing biomarkers of aging, as evidenced by their impressive portfolio of natural product solut...

Man Reverses Aging - Extended Longevity's Phytotherapeutic Formulations Continue to Amaze

MAUI, Hawaii--(BUSINESS WIRE)--Extended Longevity is thrilled to announce a groundbreaking achievement in anti-aging. A 69.9-year-old man, who after using the Extended Longevity Protocol for 3 years has now tested using the innovative GlycanAge test, (for inflammaging and the immune system) and has experienced a remarkable reversal in aging, achieving a biologically rejuvenated age of 32—a staggering 37-year transformation. The extraordinary results can be found at https://www.extendedlongevity...

Extended Longevity Clinical Trial Demonstrates Remarkable Reversal of Aging Biomarkers

MAUI, Hawaii--(BUSINESS WIRE)--Extended Longevity, a leading provider of innovative anti-aging solutions, is thrilled to announce the successful completion of the groundbreaking Longevinaut Study #1. The study, conducted under the guidance of Dr. Juergen Winkler at Quantum Functional Medicine, Carlsbad, CA, under the supervision of the Institute of Regenerative and Cellular Medicine, of Santa Monica, California, Executive Director Dr. Barbara Krutchkoff, PhD has demonstrated the safety and effe...
Back to Newsroom